363 related articles for article (PubMed ID: 26787900)
1. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.
Bhardwaj A; Das S
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E538-47. PubMed ID: 26787900
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma.
Yang H; Zhu R; Zhao X; Liu L; Zhou Z; Zhao L; Liang B; Ma W; Zhao J; Liu J; Huang G
Oncogene; 2019 Jun; 38(25):4915-4931. PubMed ID: 30858544
[TBL] [Abstract][Full Text] [Related]
3. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
[TBL] [Abstract][Full Text] [Related]
4. SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.
Park SH; Ozden O; Liu G; Song HY; Zhu Y; Yan Y; Zou X; Kang HJ; Jiang H; Principe DR; Cha YI; Roh M; Vassilopoulos A; Gius D
Cancer Res; 2016 Jul; 76(13):3802-12. PubMed ID: 27197174
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization.
Lv L; Xu YP; Zhao D; Li FL; Wang W; Sasaki N; Jiang Y; Zhou X; Li TT; Guan KL; Lei QY; Xiong Y
Mol Cell; 2013 Nov; 52(3):340-52. PubMed ID: 24120661
[TBL] [Abstract][Full Text] [Related]
6. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
7. Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth.
Xiangyun Y; Xiaomin N; Linping G; Yunhua X; Ziming L; Yongfeng Y; Zhiwei C; Shun L
Oncotarget; 2017 Jan; 8(4):6984-6993. PubMed ID: 28036303
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress.
Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY
Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265
[TBL] [Abstract][Full Text] [Related]
10. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z
Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880
[TBL] [Abstract][Full Text] [Related]
12. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
13. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor.
Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T
Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
15. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation.
Gao F; Zhang X; Wang S; Zheng L; Sun Y; Wang G; Song Z; Bao Y
Cell Death Dis; 2021 May; 12(6):517. PubMed ID: 34016961
[TBL] [Abstract][Full Text] [Related]
16. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
17. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.
Wood M; Rymarchyk S; Zheng S; Cen Y
Arch Biochem Biophys; 2018 Jan; 638():8-17. PubMed ID: 29233643
[TBL] [Abstract][Full Text] [Related]
18. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.
Yang W; Xia Y; Hawke D; Li X; Liang J; Xing D; Aldape K; Hunter T; Alfred Yung WK; Lu Z
Cell; 2012 Aug; 150(4):685-96. PubMed ID: 22901803
[TBL] [Abstract][Full Text] [Related]
19. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
[TBL] [Abstract][Full Text] [Related]
20. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]